Journal article
Impact of blood pressure lowering, cholesterol lowering and their combination in Asians and non-Asians in those without cardiovascular disease: an analysis of the HOPE 3 study
Abstract
BACKGROUND AND DESIGN: There are limited data on the effects of blood pressure and cholesterol lowering in Asians at intermediate risk and no cardiovascular disease. We report an analysis of the effects of blood pressure and cholesterol lowering in Asians enrolled in the Heart Outcomes Prevention Evaluation 3 (HOPE 3) trial.
METHODS: We randomly assigned 6241 Asians and 6464 non-Asians at intermediate risk without cardiovascular disease to …
Authors
Pais P; Jung H; Dans A; Zhu J; Liu L; Kamath D; Bosch J; Lonn E; Yusuf S
Journal
European Journal of Preventive Cardiology, Vol. 26, No. 7, pp. 681–697
Publisher
Oxford University Press (OUP)
Publication Date
5 2019
DOI
10.1177/2047487318819019
ISSN
2047-4873
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AgedAngiotensin II Type 1 Receptor BlockersAntihypertensive AgentsAsiaAsian PeopleBenzimidazolesBiomarkersBiphenyl CompoundsBlood PressureCholesterol, LDLDouble-Blind MethodDown-RegulationDrug CombinationsDyslipidemiasFemaleHumansHydrochlorothiazideHydroxymethylglutaryl-CoA Reductase InhibitorsHypertensionMaleMiddle AgedRosuvastatin CalciumSodium Chloride Symporter InhibitorsTetrazolesTime FactorsTreatment Outcome